Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

NCT07631598

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Community Health Project Los Angeles (CHPLA) Los Angeles, California, United States
  • HIPS Washington D.C., District of Columbia, United States
  • CARPBR/Be Safe Syringe Program Baton Rouge, Louisiana, United States
  • Harm Reduction Sisters Duluth, Minnesota, United States
View Trial Details
Not Yet Recruiting

ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma

NCT07247097

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Not Yet Recruiting

Neurocognitive Assessment in Long-Term Survivors of Lymphoma

NCT07652476

Conditions
Classic Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +11 more
Locations
  • Clinica di Ematologia, AOU Ospedali Riuniti Ancona, Italy
  • Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano Aviano, Italy
  • U.O.C Ematologia - IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy
  • U.O.C. Ematologia Ospedale Civile di Legnano - ASST Ovest Milanese Legnano, Italy
View Trial Details

Related conditions